YIG-CCA (@cca_yig) 's Twitter Profile
YIG-CCA

@cca_yig

Young Investigator Group of EURO-CHOLANGIO-NET Cost Action

ID: 1588566063259820033

calendar_today04-11-2022 16:17:35

64 Tweet

100 Followers

142 Following

FASEB (@faseborg) 's Twitter Profile Photo

We've got an amazing program planned for this exciting conference on a rare but virulent form of bile duct cancer. This is a first-of-its-kind event for researchers so don't miss it! #CHOSRC Mario Strazzabosco Sumera Ilyas View the program: bit.ly/3oREdje

We've got an amazing program planned for this exciting conference on a rare but virulent form of bile duct cancer. This is a first-of-its-kind event for researchers so don't miss it! #CHOSRC <a href="/MarioStrazzabos/">Mario Strazzabosco</a> <a href="/SumeraIlyasMD/">Sumera Ilyas</a>
View the program: bit.ly/3oREdje
Jordi Gracia-Sancho (@jsgracia) 's Twitter Profile Photo

Join us through this excellent funding opportunity! 👩🏼‍🔬👨🏽‍⚕️👨🏻‍💻Multidisciplinary team coordinated by Manuel Romero-Gómez Javier Cubero and 🙋🏻‍♂️ 🔬 Topic: Steatotic liver disease from bench to bedside, and viceversa 🏙️ 3 labs in 3 years ‼️ All info: postdoc-aristos.com/DetailGroup?Gr… 🫶🏼 Please RT 🫶🏼

Join us through this excellent funding opportunity!

👩🏼‍🔬👨🏽‍⚕️👨🏻‍💻Multidisciplinary team coordinated by <a href="/mromerogomez/">Manuel Romero-Gómez</a> <a href="/CUBEROlab/">Javier Cubero</a> and 🙋🏻‍♂️

🔬 Topic: Steatotic liver disease from bench to bedside, and viceversa

🏙️ 3 labs in 3 years ‼️

All info: postdoc-aristos.com/DetailGroup?Gr…

🫶🏼 Please RT 🫶🏼
Helen Morement (@helenmorement) 's Twitter Profile Photo

Pleased to have been part of UK NHSBT Transplantation for CCA FTW Group! The outcome - a pilot transplant programme for iCCA. Stringent eligibility criteria but this represents a 1st & important step forward. See paper: hrjournal.net/article/view/6… #LiverTwitter #cholangiocarcinoma

Pleased to have been part of UK NHSBT Transplantation for CCA FTW Group! The outcome - a pilot transplant programme for iCCA. Stringent eligibility criteria but this represents a 1st &amp; important step forward. See paper: hrjournal.net/article/view/6… 
 #LiverTwitter #cholangiocarcinoma
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

Long-term follow-up of patients discontinuing #bulevirtide treatment upon long-term #HDV-RNA suppression 🔓#OpenAccess at👉bit.ly/3QlzNN7 Mathias Jachs Thomas Reiberger #LiverTwitter

Long-term follow-up of patients discontinuing #bulevirtide treatment upon long-term #HDV-RNA suppression

🔓#OpenAccess at👉bit.ly/3QlzNN7

<a href="/mathiasjachs/">Mathias Jachs</a>
<a href="/ReibergerThomas/">Thomas Reiberger</a>
#LiverTwitter
Cholangiocarcinoma Foundation (@curecc) 's Twitter Profile Photo

We invite you to participate in a survey to help understand the challenges of dealing with cancer and cancer treatment and how those realities affect your quality of life. For more information and to take the survey, please visit curecca.link/QOLsurvey.

We invite you to participate in a survey to help understand the challenges of dealing with cancer and cancer treatment and how those realities affect your quality of life. 

For more information and to take the survey, please visit curecca.link/QOLsurvey.
EASLnews (@easlnews) 's Twitter Profile Photo

📣 Calling all our young investigators on #LiverTwitter! It's already back to School in 2024🔥 Discover our four EASL Schools, pick the one you are interested in, and apply today! Read more on: easl.eu/events/easl-co… EASL Education Aleksander Krag Debbie Shawcross Ahmed Elsharkawy

📣 Calling all our young investigators on #LiverTwitter! It's already back to School in 2024🔥

Discover our four EASL Schools, pick the one you are interested in, and apply today!

Read more on: easl.eu/events/easl-co…

<a href="/EASLedu/">EASL Education</a> <a href="/AleksanderKrag/">Aleksander Krag</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a> <a href="/aelsharkawy75/">Ahmed Elsharkawy</a>
EASLnews (@easlnews) 's Twitter Profile Photo

Young Investigators of #LiverTwitter, how do you interpret liver biopsies?🤔 Now's the chance to sharpen your skills with this dedicated upcoming #EASLSchool, taking place 12-13 April 2024 in Hospital Clínic 🇪🇸 with experts Alba Díaz & Xavier Forns! Read more & register now by

Young Investigators of #LiverTwitter, how do you interpret liver biopsies?🤔

Now's the chance to sharpen your skills with this dedicated upcoming #EASLSchool, taking place 12-13 April 2024 in <a href="/hospitalclinic/">Hospital Clínic</a> 🇪🇸 with experts Alba Díaz &amp; Xavier Forns!

Read more &amp; register now by
EURO-CHOLANGIO-NET (@cholangionet) 's Twitter Profile Photo

The EURO-CHOLANGIO-NET, ENS-CCA and ICRN are proud to announce the new mentorship lecture! ➡️"WOMEN IN SCIENCES: PASSION AND CHALLENGES" 🎙️Laura Fouassier 🗓️21 September, 3PM CET, 9AM EST ✏️Learn more and register here: eurocholangionet.eu/the-mentorship…

Pharmacology Valencia (@pharmacologyvlc) 's Twitter Profile Photo

LAST DAY to register for the 2nd International Workshop on Liver and Gut Fibrosis. See you in VALENCIA, 26-27 Oct! congreso.adeituv.es/fibrosisvalenc… #IBD #crohns #Fibrosis #livertwitter Y-ECCO Aegastro @CIBERehd UEG GAMING Universitat València Fundació Fisabio

LAST DAY to register for the 2nd International Workshop on Liver and Gut Fibrosis. See you in VALENCIA, 26-27 Oct! congreso.adeituv.es/fibrosisvalenc…  #IBD #crohns #Fibrosis #livertwitter <a href="/Y_ECCO_IBD/">Y-ECCO</a> <a href="/aegastro/">Aegastro</a> @CIBERehd
 <a href="/ueg/">UEG GAMING</a> <a href="/UV_EG/">Universitat València</a> <a href="/GVAfisabio/">Fundació Fisabio</a>
Flavio G Rocha, MD, FACS, FSSO (@flaviorochamd) 's Twitter Profile Photo

Cholangiocarcinoma Foundation CEO Stacie Lindsey presenting the Keynote Report 🔑 📝 at #CCA2023 from #Cholangiocarcinoma Foundation. So much has been achieved since 2006 but more needs to be done. Already looking forward to #ccfac2024 #advocacy #clinicaltrials #multiDcare

<a href="/curecc/">Cholangiocarcinoma Foundation</a> CEO <a href="/staclinds/">Stacie Lindsey</a> presenting the Keynote Report 🔑 📝 at #CCA2023 from #Cholangiocarcinoma Foundation. 

So much has been achieved since 2006 but more needs to be done. 

Already looking forward to #ccfac2024

 #advocacy #clinicaltrials #multiDcare
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Studies exploring #Cabozantinib in #NET 2/2 — CABINET (cabo vs placebo) by #JenniferChan Phase III; epNET and pNET cohorts. Early closure due to “compelling efficacy” #PFS benefit in BOTH cohorts! HR 0.45 epNET and HR 0.27 pNET 🔝🔝🔝 💪New option? (my vote -YES!) ESMO - Eur. Oncology

Studies exploring #Cabozantinib in #NET

2/2 — CABINET (cabo vs placebo) by #JenniferChan 

Phase III; epNET and pNET cohorts. Early closure due to “compelling efficacy”

#PFS benefit in BOTH cohorts! HR 0.45 epNET and HR 0.27 pNET 🔝🔝🔝

💪New option? (my vote -YES!)

<a href="/myESMO/">ESMO - Eur. Oncology</a>
Pilar Acedo (@pilar_acedo) 's Twitter Profile Photo

Still recovering from #UEGWeek... What an amazing Congress! Thanks United European Gastroenterology Community for everything, including Let's Meet & UEG Night 😉 and my Rising 🌟Award! Looking forward to #UEGWeek2024 in Vienna!

Still recovering from #UEGWeek... What an amazing Congress! Thanks <a href="/my_ueg/">United European Gastroenterology</a> Community for everything, including Let's Meet &amp; UEG Night 😉 and my Rising 🌟Award! Looking forward to #UEGWeek2024 in Vienna!
jorge_adeva_MD (@cofiadeva) 's Twitter Profile Photo

Angela Lamarca gives a brilliant review by about immunotherapy in BTC. 👉1st L --> aPDL1/PD1 + Cisgem is clearly SOC ❓️Keep QT (Gem) after 6 months along with IO?  🗨STOP cisgem after 6 months. Keep IO alone. 🗨We need biomarkers! 🗨Our patients need to have this SOC now!

<a href="/DrAngelaLamarca/">Angela Lamarca</a> gives a brilliant review by about immunotherapy in BTC.
👉1st L --&gt; aPDL1/PD1 + Cisgem is clearly SOC
❓️Keep QT (Gem) after 6 months along with IO? 
🗨STOP cisgem after 6 months. Keep IO alone.
🗨We need biomarkers!
🗨Our patients need to have this SOC now!
HPB Dublin (@hpbdublin) 's Twitter Profile Photo

Wonderful opportunity to join our stellar HPB & Transplant unit in Dublin St Vincent's University Hospital (SVUH) 🟢2 Yr Fully-Funded & Accredited Fellowship 🟢Significant Operative Experience 🟢Research Opportunities 🟢Just in time for #eahpba2025 Dublin! SVUH Surgery E-AHPBA IHPBA svhg.recruitment.zellis.com/wrl/pages/vaca…

Ana Lleo (@analleo) 's Twitter Profile Photo

🆘 CCA is a deadly cancer 🧬 preclinical research is key! 🆕 CCA-on-a-chip model just published in ⁦JHEP Reports⁩ ⁦EASLnews⁩ 🙏🏻support ⁦⁦Fondazione AIRC per la ricerca sul cancro⁩ ⁦Humanitas University⁩ ⁦Politecnico di Milano⁩ ⁦MiMicLab⁩ ⁦⁦Michela Polidoro⁩ jhep-reports.eu/action/showPdf…

EASLnews (@easlnews) 's Twitter Profile Photo

Let's build the future of hepatology together! 🤝 We are currently looking for: - 3 Scientific Committee Members - 4 Educational Committee Members - 2 Policy, Public Health, and Advocacy Committee Members - 3 Young Investigator Task Force members - 1 Nurses & AHPs Task Force

Let's build the future of hepatology together! 🤝

We are currently looking for:
- 3 Scientific Committee Members
- 4 Educational Committee Members
- 2 Policy, Public Health, and Advocacy Committee Members
- 3 Young Investigator Task Force members
- 1 Nurses &amp; AHPs Task Force
ccauk (@ccaukgroup) 's Twitter Profile Photo

Abstract submission and registration now open for the CCA-UK National Meeting on 2nd Feb 2024. Further information, including a draft programme can be found here -basl.org.uk/index.cfm/even…… #cholangiocarcinoma #bileductcancer #CCAUK2024

Abstract submission and registration now open for the CCA-UK National Meeting on 2nd Feb 2024.
Further information, including a draft programme can be found here -basl.org.uk/index.cfm/even…… 

#cholangiocarcinoma #bileductcancer #CCAUK2024